News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
512,850 Results
Type
Article (35223)
Company Profile (76)
Press Release (477551)
Section
Business (145990)
Career Advice (2365)
Deals (26578)
Drug Delivery (86)
Drug Development (70199)
Employer Resources (135)
FDA (12987)
Job Trends (11566)
News (260328)
Policy (25682)
Tag
Academia (2392)
Alliances (36271)
Alzheimer's disease (1273)
Approvals (12954)
Artificial intelligence (147)
Bankruptcy (296)
Best Places to Work (9490)
Breast cancer (187)
Cancer (1369)
Cardiovascular disease (123)
Career advice (1984)
CAR-T (95)
Cell therapy (281)
Clinical research (56535)
Collaboration (461)
Compensation (135)
COVID-19 (2325)
C-suite (142)
Data (1392)
Diabetes (177)
Diagnostics (5356)
Earnings (52099)
Employer resources (124)
Events (69586)
Executive appointments (469)
FDA (13671)
Funding (440)
Gene therapy (204)
GLP-1 (586)
Government (3919)
Healthcare (15308)
Infectious disease (2415)
Inflammatory bowel disease (102)
Interviews (513)
IPO (11947)
Job creations (2419)
Job search strategy (1627)
Layoffs (368)
Legal (5338)
Lung cancer (221)
Manufacturing (175)
Medical device (10082)
Medtech (10086)
Mergers & acquisitions (14854)
Metabolic disorders (464)
Neuroscience (1635)
NextGen: Class of 2025 (5212)
Non-profit (3787)
Northern California (1502)
Obesity (252)
Opinion (187)
Parkinson's disease (99)
Patents (123)
People (48631)
Phase I (17381)
Phase II (24911)
Phase III (19013)
Pipeline (581)
Postmarket research (2194)
Preclinical (6962)
Radiopharmaceuticals (199)
Rare diseases (254)
Real estate (3791)
Regulatory (17848)
Research institute (1983)
Resumes & cover letters (343)
Southern California (1327)
Startups (2524)
United States (13052)
Vaccines (499)
Weight loss (183)
Date
Today (93)
Last 7 days (330)
Last 30 days (1588)
Last 365 days (28985)
2025 (1401)
2024 (29351)
2023 (33033)
2022 (43275)
2021 (46257)
2020 (44761)
2019 (38061)
2018 (28840)
2017 (25871)
2016 (24457)
2015 (28633)
2014 (21272)
2013 (17137)
2012 (18309)
2011 (19387)
2010 (17118)
Location
Africa (678)
Arizona (118)
Asia (31796)
Australia (6752)
California (3368)
Canada (1353)
China (309)
Colorado (151)
Connecticut (149)
Europe (70453)
Florida (518)
Georgia (115)
Illinois (333)
Indiana (199)
Maryland (590)
Massachusetts (2378)
Michigan (160)
Minnesota (226)
New Jersey (975)
New York (962)
North Carolina (604)
Northern California (1502)
Ohio (119)
Pennsylvania (766)
South America (936)
Southern California (1327)
Texas (497)
Utah (112)
Washington State (352)
512,850 Results for "optinose as".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Optinose Announces Preliminary Unaudited Fourth Quarter 2024 XHANCE Net Revenue of $22.4 Million
January 15, 2025
·
4 min read
Press Releases
Optinose to Present at the Piper Sandler 36th Annual Healthcare Conference
December 3, 2024
·
1 min read
Press Releases
Optinose Announces Reporting Date for Third Quarter 2024 Financial Results
November 6, 2024
·
1 min read
Press Releases
Optinose Appoints Terry Kohler as Chief Financial Officer
October 7, 2024
·
7 min read
Pharm Country
Optinose Announces $55 Million Registered Direct Offering
Optinose announced that it has entered into agreements for the sale of approximately $55 million of its common stock and pre-funded common stock warrants to a group of existing and new institutional investors in a registered direct offering.
May 9, 2024
·
8 min read
Business
Optinose Reports First Quarter 2024 Financial Results and Recent Operational Highlights
Optinose, a pharmaceutical company focused on patients treated by ear, nose and throat and allergy specialists, reported financial results for the quarter ended March 31, 2024, and provided recent operational highlights.
May 14, 2024
·
11 min read
Business
Optinose Announces Reporting Date for First Quarter 2024 Financial Results
Optinose, a pharmaceutical company focused on patients treated by ear, nose and throat and allergy specialists, announced the Company will report financial results for the first quarter 2024 and corporate updates, before market open, on Tuesday, May 14, 2024.
May 10, 2024
·
1 min read
Pharm Country
Optinose to Present at the Needham Virtual Healthcare Conference - April 04, 2024
Optinose announced that members of its management team will present a company overview and business update at the Needham Virtual Healthcare Conference on April 10, 2024 at 2:15 p.m. ET.
April 4, 2024
·
1 min read
Business
Optinose Provides Corporate Update on XHANCE Launch and Outlook and Announces Preliminary First Quarter 2024
Optinose today announced corporate updates detailing its commercial plans and expectations for XHANCE ® (fluticasone propionate) following the recent FDA approval of a new indication for the treatment of chronic rhinosinusitis without nasal polyps in patients 18 year of age and older.
April 25, 2024
·
8 min read
Press Releases
Optinose Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - October 16, 2024
October 17, 2024
·
1 min read
1 of 51,285
Next
